UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 74

Sortiert nach

Combined Proteomics and Transcriptomics Identifies Carboxypeptidase B1 and Nuclear Factor κB (NF-κB) Associated Proteins as Putative Biomarkers of Metastasis in Low Grade Breast Cancer

Molecular & cellular proteomics, 2015-07, Vol.14 (7), p.1814-1830

2015

Link zum Volltext

Verfügbarkeit prüfen

Weight Concerns Associated With Delay in Quit Date But Not Treatment Outcomes: A Czech Republic Experience

Nicotine & tobacco research, 2018-01, Vol.20 (1), p.89-94

2018

Link zum Volltext

Verfügbarkeit prüfen

When should empirical antibiotic therapy be indicated in acute community-onset diarrhea of suspected bacterial etiology

Klinicka mikrobiologie a infekcni lekarstvi, 2015-03, Vol.21 (1), p.24

2015

Link zum Volltext

Verfügbarkeit prüfen

Estimating Cancer Incidence, Prevalence, and the Number of Cancer Patients Treated with Anti-tumor Th erapy in 2015 and 2020 – Analysis of the Czech National Cancer Registry

Klinická onkologie, 2015-02, Vol.28 (1), p.30-43

2015

Link zum Volltext

Verfügbarkeit prüfen

Bevacizumab with chemotherapy in patients with KRAS wild-type metastatic colorectal cancer: Czech registry data

Future oncology (London, England), 2015, Vol.11 (2), p.225-232

2015

Link zum Volltext

Verfügbarkeit prüfen

The interval between progression and therapy initiation is the key prognostic parameter in relapsing diffuse large B cell lymphoma: analysis from the Czech Lymphoma Study Group database (NIHIL)

Annals of hematology, 2020-07, Vol.99 (7), p.1583-1594

2020

Link zum Volltext

Verfügbarkeit prüfen

PET-CT documented complete remission of Erdheim-Chester disease, lasting more than 4 years from treatment initiation with cladribine

Vnitřní lékar̆stvĭ, 2014-05, Vol.60 (5-6), p.499, 501-499

2014

Link zum Volltext

Verfügbarkeit prüfen

Continuation maintenance therapy with pemetrexed in patients with non-small-cell lung cancer in the Czech Republic

Onkologie (Olomouc), 2016-03, Vol.10 (1), p.31-36

2016

Link zum Volltext

Verfügbarkeit prüfen

Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry

BMC cancer, 2017-12, Vol.17 (1), p.880-880, Article 880

2017

Link zum Volltext

Verfügbarkeit prüfen

Epidemiological and clinico-pathological characteristics of patients with renal carcinoma: a single institution analysis of 544 cases

Klinická onkologie, 2013, Vol.26 (2), p.114-123

2013

Link zum Volltext

Verfügbarkeit prüfen

Locally advanced breast cancer in elderly patients

Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia, 2017-06, Vol.161 (2), p.217-222

2017

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of everolimus in second- and third-line therapy for metastatic renal cell carcinoma: A registry-based analysis

Urologic oncology, 2014-07, Vol.32 (5), p.569-575

2014

Link zum Volltext

Verfügbarkeit prüfen

Clinical and laboratory prognostic factors in patients with metastatic renal cell carcinoma treated with sunitinib and sorafenib after progression on cytokines

Urologic oncology, 2014-05, Vol.32 (4), p.488-495

2014

Link zum Volltext

Verfügbarkeit prüfen

Various forms of 18F-FDG PET and PET/CT findings in patients with polymyalgia rheumatica

Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia, 2015-12, Vol.159 (4), p.629-636

2015

Link zum Volltext

Verfügbarkeit prüfen

PET/CT imaging in polymyalgia rheumatica: praepubic 18F-FDG uptake correlates with pectineus and adductor longus muscles enthesitis and with tenosynovitis

Radiology and oncology, 2017-01, Vol.51 (1), p.8-14

2017

Link zum Volltext

Verfügbarkeit prüfen

The Prognostic Role of KRAS Mutation in Patients with Advanced NSCLC Treated with Second- or Third-line Chemotherapy

Anticancer research, 2016-03, Vol.36 (3), p.1077-1082

2016

Link zum Volltext

Verfügbarkeit prüfen

Outcomes for Patients with Metastatic Renal Cell Carcinoma Achieving a Complete Response on Targeted Therapy: A Registry-based Analysis

European urology, 2016-09, Vol.70 (3), p.469-475

2016

Link zum Volltext

Verfügbarkeit prüfen

Predictive role of CEA and CYFRA 21-1 in patients with advanced-stage NSCLC treated with erlotinib

Anticancer research, 2014-06, Vol.34 (6), p.3205-3210

2014

Link zum Volltext

Verfügbarkeit prüfen

Statins augment efficacy of EGFR-TKIs in patients with advanced-stage non-small cell lung cancer harbouring KRAS mutation

Tumor biology, 2015-08, Vol.36 (8), p.5801-5805

2015

Link zum Volltext

Verfügbarkeit prüfen

First-line therapy for T cell lymphomas: a retrospective population-based analysis of 906 T cell lymphoma patients

Annals of hematology, 2019-08, Vol.98 (8), p.1961-1972

2019

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Toxicity of Panitumumab After Progression on Cetuximab and Predictive Value of MiR-31-5p in Metastatic Wild-type KRAS Colorectal Cancer Patients

Anticancer research, 2016-09, Vol.36 (9), p.4955-4959

2016

Link zum Volltext

Verfügbarkeit prüfen

Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with Erlotinib

Anticancer research, 2016-05, Vol.36 (5), p.2459-2465

2016

Link zum Volltext

Verfügbarkeit prüfen

G12V and G12A KRAS mutations are associated with poor outcome in patients with metastatic colorectal cancer treated with bevacizumab

Tumor biology, 2016-05, Vol.37 (5), p.6823-6830

2016

Link zum Volltext

Verfügbarkeit prüfen

Comparing Clinical Characteristics and Outcomes of Young-onset and Late-onset Colorectal Cancer: An International Collaborative Study

Clinical colorectal cancer, 2017-12, Vol.16 (4), p.334-342

2017

Link zum Volltext

Verfügbarkeit prüfen

Epidermal Growth Factor Receptor Gene Amplification in Patients with Advanced-stage NSCLC

Anticancer research, 2016-01, Vol.36 (1), p.455-460

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 74

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(69)

Publikationsform

Artikel
(73)
Berichte
(1)

Sprache

Englisch
(72)
Tschechisch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(45)
Life Sciences & Biomedicine
(43)
Science & Technology
(43)
Male
(39)
Female
(38)
Middle Aged
(38)
Aged
(36)
Adult
(32)
Oncology
(31)
Retrospective Studies
(26)
Aged, 80 And Over
(24)
Disease-Free Survival
(19)
Treatment Outcome
(18)
Prognosis
(14)
Antineoplastic Agents - Therapeutic Use
(13)
Neoplasm Metastasis
(13)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(11)
Colorectal Neoplasms - Pathology
(10)
Lung Neoplasms - Drug Therapy
(10)
Neoplasm Staging
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Combined Proteomics and Transcriptomics Identifies Carboxypeptidase B1 and Nuclear Factor κB (NF-κB) Associated Proteins as Putative Biomarkers of Metastasis in Low Grade Breast Cancer

Weight Concerns Associated With Delay in Quit Date But Not Treatment Outcomes: A Czech Republic Experience

When should empirical antibiotic therapy be indicated in acute community-onset diarrhea of suspected bacterial etiology

Estimating Cancer Incidence, Prevalence, and the Number of Cancer Patients Treated with Anti-tumor Th erapy in 2015 and 2020 – Analysis of the Czech National Cancer Registry

Bevacizumab with chemotherapy in patients with KRAS wild-type metastatic colorectal cancer: Czech registry data

The interval between progression and therapy initiation is the key prognostic parameter in relapsing diffuse large B cell lymphoma: analysis from the Czech Lymphoma Study Group database (NIHIL)

PET-CT documented complete remission of Erdheim-Chester disease, lasting more than 4 years from treatment initiation with cladribine

Continuation maintenance therapy with pemetrexed in patients with non-small-cell lung cancer in the Czech Republic

Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry

Epidemiological and clinico-pathological characteristics of patients with renal carcinoma: a single institution analysis of 544 cases

Locally advanced breast cancer in elderly patients

Efficacy of everolimus in second- and third-line therapy for metastatic renal cell carcinoma: A registry-based analysis

Clinical and laboratory prognostic factors in patients with metastatic renal cell carcinoma treated with sunitinib and sorafenib after progression on cytokines

Various forms of 18F-FDG PET and PET/CT findings in patients with polymyalgia rheumatica

PET/CT imaging in polymyalgia rheumatica: praepubic 18F-FDG uptake correlates with pectineus and adductor longus muscles enthesitis and with tenosynovitis

The Prognostic Role of KRAS Mutation in Patients with Advanced NSCLC Treated with Second- or Third-line Chemotherapy

Outcomes for Patients with Metastatic Renal Cell Carcinoma Achieving a Complete Response on Targeted Therapy: A Registry-based Analysis

Predictive role of CEA and CYFRA 21-1 in patients with advanced-stage NSCLC treated with erlotinib

Statins augment efficacy of EGFR-TKIs in patients with advanced-stage non-small cell lung cancer harbouring KRAS mutation

First-line therapy for T cell lymphomas: a retrospective population-based analysis of 906 T cell lymphoma patients

Efficacy and Toxicity of Panitumumab After Progression on Cetuximab and Predictive Value of MiR-31-5p in Metastatic Wild-type KRAS Colorectal Cancer Patients

Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with Erlotinib

G12V and G12A KRAS mutations are associated with poor outcome in patients with metastatic colorectal cancer treated with bevacizumab

Comparing Clinical Characteristics and Outcomes of Young-onset and Late-onset Colorectal Cancer: An International Collaborative Study

Epidermal Growth Factor Receptor Gene Amplification in Patients with Advanced-stage NSCLC

Suchergebnisse filtern